Somatostatin sensitivity and growth hormone responses to releasing hormones and bromocryptine in acromegaly.

Suppr

超能文献

作者信息

Pieters G F, Romeijn J E, Smals A G, Kloppenborg P W

出版信息

J Clin Endocrinol Metab. 1982 May;54(5):942-8. doi: 10.1210/jcem-54-5-942.

DOI:10.1210/jcem-54-5-942

PMID:6120951

Abstract

摘要

相似文献

Somatostatin sensitivity and growth hormone responses to releasing hormones and bromocryptine in acromegaly.

J Clin Endocrinol Metab. 1982 May;54(5):942-8. doi: 10.1210/jcem-54-5-942.

Modifications in serum growth hormone concentration induced by sulpiride in acromegalic patients pretreated with dopamine, bromocriptine, and metergoline.

J Clin Endocrinol Metab. 1980 Sep;51(3):454-61. doi: 10.1210/jcem-51-3-454.

Effects of thyroliberin (TRH), bromocriptine and cyproheptadine on somatotropin secretion in acromegaly.

Mater Med Pol. 1980 Jan-Jun;12(1-2):70-3.

Studies on the response of growth hormone (GH) secretion to GH-releasing hormone, thyrotropin-releasing hormone, gonadotropin-releasing hormone, and somatostatin in acromegaly.

J Clin Endocrinol Metab. 1986 Jul;63(1):167-73. doi: 10.1210/jcem-63-1-167.

Failure of somatostatin to suppress thyrotropin releasing factor and luteinizing hormone releasing factor-induced growth hormone release in acromegaly.

J Clin Endocrinol Metab. 1974 May;38(5):906-9. doi: 10.1210/jcem-38-5-906.

Long-term treatment of acromegaly with bromocryptine: postprandial HGH levels and response to TRH and glucose administration.

Horm Metab Res. 1976 Jul;8(4):291-5. doi: 10.1055/s-0028-1093638.

Paradoxic elevation in serum GH by hypothalamic releasing hormones predicts GH response to acute SMS 201-995 administration.

Recenti Prog Med. 1991 Jan;82(1):13-6.

[Hormonal evaluation of 27 patients with acromegaly].

Med Clin (Barc). 1985 Feb 16;84(6):219-22.

The spectrum of pituitary growth hormone responses to pharmacological stimuli in acromegaly.

J Clin Endocrinol Metab. 1980 Aug;51(2):292-7. doi: 10.1210/jcem-51-2-292.

Growth hormone and changes in the secretion of thyrotropic hormone after thyrotropin-releasing hormone (TRH): ineffectiveness of dopaminergic stimulation.

Endokrinologie. 1982 Oct;80(2):201-6.

引用本文的文献

The growth hormone responses to L-dopa and TRH in acromegaly.

J Endocrinol Invest. 1984 Jun;7(3):235-7. doi: 10.1007/BF03348430.

Recent developments in acromegaly: a review.

J R Soc Med. 1983 Nov;76(11):947-56. doi: 10.1177/014107688307601112.

The effects of growth hormone-releasing factor (GRF) and dopamine on growth hormone (GH) secretion in acromegaly.

J Endocrinol Invest. 1985 Jun;8(3):203-6. doi: 10.1007/BF03348478.

The effect of long acting somatostatin analogue SMS 201-995 in acromegaly.

Korean J Intern Med. 1987 Jul;2(2):176-83. doi: 10.3904/kjim.1987.2.2.176.

Octreotide. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in conditions associated with excessive peptide secretion.

Drugs. 1989 Nov;38(5):658-702. doi: 10.2165/00003495-198938050-00002.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验